Original Article
Molecular Psychiatry (2009) 14, 774–785; doi:10.1038/mp.2008.135; published online 30 December 2008
Meta-analysis of 32 genome-wide linkage studies of schizophrenia
M Y M Ng1, D F Levinson2, S V Faraone3, B K Suarez4, L E DeLisi5,6, T Arinami7, B Riley8, T Paunio9,10, A E Pulver11, Irmansyah12, P A Holmans13, M Escamilla14, D B Wildenauer15, N M Williams13, C Laurent16, B J Mowry17, L M Brzustowicz18, M Maziade19, P Sklar20, D L Garver21, G R Abecasis22, B Lerer23, M D Fallin24, H M D Gurling25, P V Gejman26, E Lindholm27, H W Moises28, W Byerley29, E M Wijsman30, P Forabosco1, M T Tsuang31,32, H-G Hwu33, Y Okazaki34, K S Kendler8, B Wormley8, A Fanous35,36, D Walsh37, F A O'Neill38, L Peltonen39,40,41,42, G Nestadt11, V K Lasseter11, K Y Liang43, G M Papadimitriou44, D G Dikeos44, S G Schwab45,46,47, M J Owen13, M C O'Donovan13, N Norton13, E Hare14, H Raventos48, H Nicolini49, M Albus50, W Maier51, V L Nimgaonkar52, L Terenius53, J Mallet54, M Jay55, S Godard56, D Nertney57, M Alexander2, R R Crowe58, J M Silverman59, A S Bassett60, M-A Roy19, C Mérette19, C N Pato61, M T Pato61, J Louw Roos62, Y Kohn23, D Amann-Zalcenstein63, G Kalsi25, A McQuillin25, D Curtis64, J Brynjolfson65, T Sigmundsson65, H Petursson65, A R Sanders26, J Duan26, E Jazin27, M Myles-Worsley66, M Karayiorgou67 and C M Lewis1,68
- 1King's College London, Department of Medical and Molecular Genetics, London, UK
- 2Department of Psychiatry, Stanford University, Stanford, CA, USA
- 3Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA
- 4Washington University in St Louis, St Louis, MO, USA
- 5Department of Psychiatry, The New York University Langone Medical Center, New York, NY, USA
- 6Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY, USA
- 7Department of Medical Genetics, University of Tsukuba, Tsukuba, Japan
- 8Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA
- 9National Public Health Institute, Helsinki, Finland
- 10Department of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland
- 11Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 12Department of Psychiatry, University of Indonesia, Jakarta, Indonesia
- 13Department of Psychological Medicine, School of Medicine, Cardiff University, Cardiff, UK
- 14University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
- 15Center for Clinical Research in Neuropsychiatry, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, WA, Australia
- 16Department of Child Psychiatry, Université Pierre et Marie Curie and Hôpital de la Pitiè-Salpêtrière, Paris, France
- 17Queensland Centre for Mental Health Research and University of Queensland, Brisbane, QLD, Australia
- 18Department of Genetics, Rutgers University, Piscataway, NJ, USA
- 19Department of Psychiatry, Laval University & Centre de recherche Université Laval Robert-Giffard, Québec, QC, Canada
- 20Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- 21VA Medical Center, Asheville, NC, USA
- 22Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA
- 23Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
- 24Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 25Department of Mental Health Sciences, University College London, London, UK
- 26Center for Psychiatric Genetics, NorthShore University HealthSystem Research Institute and Northwestern University, Evanston, IL, USA
- 27Department of Development & Genetics, Uppsala University, Uppsala, Sweden
- 28University of Kiel, Kiel, Germany
- 29University of California, San Francisco, CA, USA
- 30Departments of Medicine and Biostatistics, University of Washington, Seattle, WA, USA
- 31Center for Behavioral Genomics and Department of Psychiatry, University of California, San Diego, CA, USA
- 32Harvard Institute of Psychiatric Epidemiology & Genetics, Boston, MA, USA
- 33National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
- 34Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan
- 35Washington VA Medical Center, Washington, DC, USA
- 36Department of Psychiatry, Georgetown University Medical Center, Virginia Commonwealth University, Richmond, VA, USA
- 37The Health Research Board, Dublin, Ireland
- 38Department of Psychiatry, Queens University, Belfast, Northern Ireland
- 39Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
- 40Department of Medical Genetics, University of Helsinki, Helsinki, Finland
- 41The Broad Institute, MIT, Boston, MA, USA
- 42Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK
- 43Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
- 441st Department of Psychiatry, University of Athens Medical School, and University Mental Health Research Institute, Athens, Greece
- 45Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia
- 46School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, WA, Australia
- 47School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
- 48School of Biology and CIBCM, University of Costa Rica, San Jose, Costa Rica
- 49Carracci Medical Group and Universidad Autonoma de la Ciudad de Mexico, Mexico City, Mexico
- 50State Mental Hospital, Haar, Germany
- 51Department of Psychiatry, University of Bonn, Bonn, Germany
- 52Departments of Psychiatry and Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA
- 53Department of Clinical Neuroscience, Karolinska Hospital, Stockholm, Sweden
- 54Laboratoire de Génétique Moléculaire de la Neurotransmission et des Processus Neurodégénératifs, Centre National de la Recherche Scientifique, Hôpital de la Pitié Salpêtrière, Paris, France
- 55Department of Child Psychiatry, Université Pierre et Marie Curie and Hôpital de la Pitiè-Salpêtrière, Paris, France
- 56INSERM, Institut de Myologie, Hôpital de la Pitiè-Salpêtrière, Paris, France
- 57Queensland Centre for Mental Health Research and University of Queensland, Brisbane, QLD, Australia
- 58Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA
- 59Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
- 60Clinical Genetics Research Program, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada
- 61Center for Genomic Psychiatry, University of Southern California, Los Angeles, CA, USA
- 62Department of Psychiatry, University of Pretoria, Weskoppies Hospital, Pretoria, Republic of South Africa
- 63Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
- 64Department of Psychological Medicine, St Bartholomew's and Royal London School of Medicine and Dentistry, London, UK
- 65Department of Psychiatry, General Hospital, Reykjavik, Iceland
- 66Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA
- 67Departments of Psychiatry and Genetics & Development, Columbia University Medical Center, New York, NY, USA
- 68King's College London, MRC SGDP Centre, Institute of Psychiatry, London, UK
Correspondence: Dr CM Lewis, Department of Medical and Molecular Genetics, King's College London, 8th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. E-mail: Cathryn.lewis@kcl.ac.uk
Received 9 October 2008; Accepted 11 November 2008; Published online 30 December 2008.
Abstract
A genome scan meta-a nalysis (GSMA) was carried out on 32 independent genome-wide linkage scan analyses that included 3255 pedigrees with 7413 genotyped cases affected with schizophrenia (SCZ) or related disorders. The primary GSMA divided the autosomes into 120 bins, rank-ordered the bins within each study according to the most positive linkage result in each bin, summed these ranks (weighted for study size) for each bin across studies and determined the empirical probability of a given summed rank (PSR) by simulation. Suggestive evidence for linkage was observed in two single bins, on chromosomes 5q (142–168 Mb) and 2q (103–134 Mb). Genome-wide evidence for linkage was detected on chromosome 2q (119–152 Mb) when bin boundaries were shifted to the middle of the previous bins. The primary analysis met empirical criteria for 'aggregate' genome-wide significance, indicating that some or all of 10 bins are likely to contain loci linked to SCZ, including regions of chromosomes 1, 2q, 3q, 4q, 5q, 8p and 10q. In a secondary analysis of 22 studies of European-ancestry samples, suggestive evidence for linkage was observed on chromosome 8p (16–33 Mb). Although the newer genome-wide association methodology has greater power to detect weak associations to single common DNA sequence variants, linkage analysis can detect diverse genetic effects that segregate in families, including multiple rare variants within one locus or several weakly associated loci in the same region. Therefore, the regions supported by this meta-analysis deserve close attention in future studies.
Keywords:
genome, human, humans, schizophrenia/genetics, genetic predisposition to disease, linkage (genetics), meta-analysis
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus
Genes and Immunity Scientific Correspondence
Molecular Psychiatry Original Article
Meta-analysis of genome-wide linkage studies for multiple sclerosis, using an extended GSMA method
European Journal of Human Genetics Article Response
Molecular Psychiatry Letter
